Evidence map›Paper›PMID 41437237›Full record

ArticleBMC public health2025

PrEP public policies for HIV prevention in South America: an intersectional analysis.

Kris Herik de Oliveira, Breno de Oliveira Ferreira, Fernando Joaquim da Silva Junior, Luiz Fernando Greiner Barp, Carolina Bonomi de Menezes Guerra, Flávia Danielle da Silva Câmara, Marianna Agnes de Almeida Soares, Gabriela Bercht, Isabelle Brambilla Honorato, Agostina Aixa Gagliolo and 7 more

Abstract read
In one paragraph

Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Kris Herik de OliveiraUniversidade de São Paulo, São Paulo, Brasil. kris.h.oliveira@gmail.com.ORCID http://orcid.org/0000-0002-0530-2513
Breno de Oliveira FerreiraUniversidade Federal do Amazonas, Manaus, Brasil.ORCID http://orcid.org/0000-0002-0979-3911
Fernando Joaquim da Silva JuniorUniversidade Federal do Rio Grande do Norte, Natal, Brasil.ORCID http://orcid.org/0000-0003-1611-7417
Luiz Fernando Greiner BarpUniversidade Federal de Santa Catarina, Florianópolis, Brasil.ORCID http://orcid.org/0000-0001-5256-8712
Carolina Bonomi de Menezes GuerraUniversidade Estadual de Campinas, Campinas, Brasil.ORCID http://orcid.org/0000-0001-8953-265X
Flávia Danielle da Silva CâmaraUniversidade Federal do Pará, Belém, Brasil.ORCID http://orcid.org/0000-0002-3070-9649
Marianna Agnes de Almeida SoaresUniversidade Federal de Mato Grosso do Sul, Campo Grande, Brasil.ORCID http://orcid.org/0000-0002-9460-6147
Gabriela BerchtUniversidade Federal do Rio Grande do Sul, Porto Alegre, Brasil.ORCID http://orcid.org/0000-0003-3616-9265
Isabelle Brambilla HonoratoUniversidade do Estado do Amazonas, Manaus, Brasil.ORCID http://orcid.org/0000-0001-9556-4615
Agostina Aixa GaglioloUniversidad de Buenos Aires, Buenos Aires, Argentina.ORCID http://orcid.org/0000-0003-0985-8671
María Guadalupe GarcíaUniversidad de Buenos Aires, Buenos Aires, Argentina.ORCID http://orcid.org/0000-0003-1650-0600
Ramon Pereira Dos ReisUniversidade do Estado do Pará, Belém, Brasil.ORCID http://orcid.org/0000-0001-8924-2097
Guilherme Rodrigues PassamaniUniversidade Federal de Mato Grosso do Sul, Campo Grande, Brasil.ORCID http://orcid.org/0000-0001-5019-0832
Bruno Silva KaussUniversidade Federal do Rio Grande do Sul, Porto Alegre, Brasil.ORCID http://orcid.org/0000-0001-8753-5574
Fernando Ruiz VallejoUniversidad Nacional de Colombia, Bogotá, Colombia.ORCID http://orcid.org/0000-0003-1121-2562
Julio Cesar Aguilera HurtadoUniversidad Autónoma Gabriel Rene Moreno, Santa Cruz de La Sierra, Bolivia.ORCID http://orcid.org/0000-0001-8637-2427
André Luiz Machado das NevesUniversidade Federal do Amazonas, Manaus, Brasil.ORCID http://orcid.org/0000-0001-7400-7596

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico , Brasil Grant numbers 445070/2023-4 and 405770/2024-3
6 · The paper itself

Abstract

backgroundHIV pre-exposure prophylaxis (PrEP) is a highly effective biomedical prevention strategy, recommended by the World Health Organization since 2015. However, in South America, its adoption has been uneven, reflecting structural, political, and socio-cultural inequalities. This study maps and analyzes national PrEP policies across 13 South American countries through an intersectional lens, identifying challenges and opportunities for more equitable HIV prevention strategies.

methodsWe conducted a documentary survey of national PrEP-related policies, clinical guidelines, regulations, and public communications from Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, Guyana, French Guiana, Paraguay, Peru, Suriname, Uruguay, and Venezuela. Searches were performed on institutional websites in Portuguese, Spanish, English, and French using predefined keywords. In the absence of official policy documents, information was collected from media and civil society sources. Data from 118 documents were coded and analyzed using iterative summative content analysis, integrating intersectionality theory to assess how policies address (or neglect) structural inequalities.

resultsTen countries have formal national PrEP policies (Argentina, Brazil, Chile, Colombia, Ecuador, Guyana, French Guiana, Paraguay, Peru, Uruguay), with Brazil pioneering implementation in 2017. Three countries (Bolivia, Suriname, Venezuela) lack comprehensive national guidelines. Most countries recommend daily oral PrEP; on-demand dosing is approved in fewer contexts, often with restrictions. Long-acting injectable cabotegravir has been approved only in Brazil, French Guiana, and Peru, but remains largely unavailable. Geographic coverage ranges from national to highly localized models. Prioritized groups include men who have sex with men, transgender women, sex workers, serodifferent couples, and, in some countries, people who use drugs. Policy formulation involves ministries of health, academia, international organizations, and, variably, civil society. However, inclusion of marginalized populations and integration of intersectional approaches remain limited. There are inequalities in the incorporation of social markers of difference in PrEP policies across the region, with greater emphasis on sexuality, gender, class, and health conditions, and limited attention to race/ethnicity, territory, generation, and disability.

conclusionPrEP policy adoption in South America demonstrates significant heterogeneity, shaped by intersecting social, political, and institutional factors. While the region has made notable advances, access remains uneven, with structural barriers such as stigma, regulatory gaps, and geographic inequities limiting impact. Incorporating intersectional perspectives into policy design and implementation is essential to ensure that PrEP - in all its modalities - is accessible as a right to health, addressing differences across multiple social, geographic, and economic dimensions.

Indexed as

Health PolicyHIV InfectionsPre-Exposure ProphylaxisPublic PolicyHumansSouth AmericaHealth equityHealth policyHIVIntersectionalityPre-Exposure ProphylaxisPreventionPublic policySouth AmericaStructural inequalities

Identifiers

PMID41437237
PMCPMC12837304

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.